ARID2 and melanoma: The attenuation of ARID2 is associated with a STAT1‐mediated upsurge in chemokines such as CXCL9, CXCL10, and CCL5, which has implications for melanoma's responsiveness to immune checkpoint inhibitors, specifically enhancing the recruitment and penetration of cytotoxic CD8+ T cells.241